Extent of surgery for differentiated thyroid cancer

Alan P B Dackiw, Martha Zeiger

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

It is the authors' opinion that total or near-total thyroidectomy followed by 131I ablation and thyroid hormone suppression therapy are the recommended extent of surgery and treatment of choice in differentiated thyroid cancer. These recommendations are based on the retrospective data, discussed above, showing that total thyroidectomy plus 131I and TSH suppression reduces disease recurrence and mortality, removes all intrathyroidal cancer, and facilitates the use of 131I scans and thyroglobulin measurements to monitor for recurrence. This recommendation is also supported by the recent decision analyses summarized above. This recommendation comes with the caveat that total thyroidectomy must be performed safely with a low complication rate. With the institution of this appropriate treatment regimen, the prognosis for the majority of our patients with differentiated thyroid cancer is excellent.

Original languageEnglish (US)
Pages (from-to)817-832
Number of pages16
JournalSurgical Clinics of North America
Volume84
Issue number3
DOIs
StatePublished - Jun 2004

Fingerprint

Thyroidectomy
Thyroid Neoplasms
Recurrence
Decision Support Techniques
Thyroglobulin
Thyroid Hormones
Therapeutics
Mortality
Neoplasms

ASJC Scopus subject areas

  • Surgery

Cite this

Extent of surgery for differentiated thyroid cancer. / Dackiw, Alan P B; Zeiger, Martha.

In: Surgical Clinics of North America, Vol. 84, No. 3, 06.2004, p. 817-832.

Research output: Contribution to journalArticle

@article{00fc4b28fc244cfaaf73edb88637ef64,
title = "Extent of surgery for differentiated thyroid cancer",
abstract = "It is the authors' opinion that total or near-total thyroidectomy followed by 131I ablation and thyroid hormone suppression therapy are the recommended extent of surgery and treatment of choice in differentiated thyroid cancer. These recommendations are based on the retrospective data, discussed above, showing that total thyroidectomy plus 131I and TSH suppression reduces disease recurrence and mortality, removes all intrathyroidal cancer, and facilitates the use of 131I scans and thyroglobulin measurements to monitor for recurrence. This recommendation is also supported by the recent decision analyses summarized above. This recommendation comes with the caveat that total thyroidectomy must be performed safely with a low complication rate. With the institution of this appropriate treatment regimen, the prognosis for the majority of our patients with differentiated thyroid cancer is excellent.",
author = "Dackiw, {Alan P B} and Martha Zeiger",
year = "2004",
month = "6",
doi = "10.1016/j.suc.2004.03.001",
language = "English (US)",
volume = "84",
pages = "817--832",
journal = "Surgical Clinics of North America",
issn = "0039-6109",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Extent of surgery for differentiated thyroid cancer

AU - Dackiw, Alan P B

AU - Zeiger, Martha

PY - 2004/6

Y1 - 2004/6

N2 - It is the authors' opinion that total or near-total thyroidectomy followed by 131I ablation and thyroid hormone suppression therapy are the recommended extent of surgery and treatment of choice in differentiated thyroid cancer. These recommendations are based on the retrospective data, discussed above, showing that total thyroidectomy plus 131I and TSH suppression reduces disease recurrence and mortality, removes all intrathyroidal cancer, and facilitates the use of 131I scans and thyroglobulin measurements to monitor for recurrence. This recommendation is also supported by the recent decision analyses summarized above. This recommendation comes with the caveat that total thyroidectomy must be performed safely with a low complication rate. With the institution of this appropriate treatment regimen, the prognosis for the majority of our patients with differentiated thyroid cancer is excellent.

AB - It is the authors' opinion that total or near-total thyroidectomy followed by 131I ablation and thyroid hormone suppression therapy are the recommended extent of surgery and treatment of choice in differentiated thyroid cancer. These recommendations are based on the retrospective data, discussed above, showing that total thyroidectomy plus 131I and TSH suppression reduces disease recurrence and mortality, removes all intrathyroidal cancer, and facilitates the use of 131I scans and thyroglobulin measurements to monitor for recurrence. This recommendation is also supported by the recent decision analyses summarized above. This recommendation comes with the caveat that total thyroidectomy must be performed safely with a low complication rate. With the institution of this appropriate treatment regimen, the prognosis for the majority of our patients with differentiated thyroid cancer is excellent.

UR - http://www.scopus.com/inward/record.url?scp=2442495444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442495444&partnerID=8YFLogxK

U2 - 10.1016/j.suc.2004.03.001

DO - 10.1016/j.suc.2004.03.001

M3 - Article

C2 - 15145237

AN - SCOPUS:2442495444

VL - 84

SP - 817

EP - 832

JO - Surgical Clinics of North America

JF - Surgical Clinics of North America

SN - 0039-6109

IS - 3

ER -